Merck Invests More Than € 300 Million in New Life Science Research Center in Germany
Research center to accelerate biopharmaceutical product development
26-Apr-2024 -
Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...
cell culture media
investments
recombinant proteins
+2